- Bryan Johnson’s chronic disease is notoriously difficult to diagnoseWhy longevity entrepreneur Bryan Johnson’s chronic disease is notoriously difficult to diagnose.STAT · 20d ago↗ source
- HHS lays groundwork for new FDA rule on releasing CRLsThe Trump administration is pushing the FDA to cement the details behind its proactive public release of rejection letters sent to pharma companies. The push comes as an HHS spokesperson confirmed…Endpoints · 20d ago↗ source
- AstraZeneca, GSK intensify China ties with Sino Biopharm dealsThe U.K. drugmakers added to a series of recent tie-ups with Chinese counterparts amid broader scrutiny of such transactions in the U.S.BioPharma Dive · 20d ago↗ source